News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
884,836 Results
Type
Article (88866)
Company Profile (816)
Press Release (795132)
Multimedia
Podcasts (242)
Webinars (35)
Section
Business (233632)
Career Advice (4164)
Deals (40008)
Drug Delivery (180)
Drug Development (91749)
Employer Resources (207)
FDA (18575)
Job Trends (17492)
News (398819)
Policy (40020)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3055)
Academic (2)
Accelerated approval (58)
ADA (49)
Adcomms (42)
Allergies (208)
Alliances (56990)
ALS (242)
Alzheimer's disease (1983)
Antibody-drug conjugate (ADC) (573)
Approvals (18945)
Artificial intelligence (897)
ASCO (345)
Autoimmune disease (371)
Automation (69)
Bankruptcy (409)
Best Places to Work (12635)
BIO (73)
BIOSECURE Act (23)
Biosimilars (250)
Biotechnology (482)
Bladder cancer (214)
Brain cancer (86)
Breast cancer (852)
Cancer (6698)
Cardiovascular disease (565)
Career advice (3600)
Career pathing (52)
CAR-T (390)
CDC (77)
Celiac Disease (3)
Cell therapy (1091)
Cervical cancer (57)
Clinical research (79219)
Collaboration (2422)
Commercialization (1)
Company closure (8)
Compensation (1543)
Complete response letters (107)
COVID-19 (3044)
CRISPR (127)
C-suite (1318)
Cystic fibrosis (168)
Data (8846)
Decentralized trials (3)
Denatured (93)
Depression (199)
Dermatology (99)
Diabetes (717)
Diagnostics (7623)
Digital health (71)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (451)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (322)
Earnings (102513)
Editorial (80)
Employer branding (25)
Employer resources (175)
Events (138861)
Executive appointments (1207)
FDA (22739)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (36)
Funding (1994)
Gene editing (276)
Generative AI (91)
Gene therapy (862)
GLP-1 (1293)
Government (5569)
Grass and pollen (8)
Guidances (423)
Healthcare (21270)
Hematology (198)
HIV (99)
Huntington's disease (67)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (360)
Immuno-oncology (116)
Indications (217)
Infectious disease (3452)
Inflammatory bowel disease (245)
Inflation Reduction Act (17)
Influenza (154)
Intellectual property (328)
Interviews (822)
IPO (18008)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (23)
Labor market (125)
Layoffs (693)
Leadership (54)
Legal (10171)
Liver cancer (111)
Longevity (38)
Lung cancer (884)
Lymphoma (483)
Machine learning (70)
Management (67)
Manufacturing (1266)
Marketing (2)
MASH (229)
Medical affairs (1)
Medical device (15296)
Medtech (15473)
Mergers & acquisitions (23322)
Metabolic disorders (1853)
mRNA (275)
Multiple sclerosis (210)
NASH (24)
Neurodegenerative disease (522)
Neuropsychiatric disorders (130)
Neuroscience (3772)
Neurotech (2)
NextGen: Class of 2026 (7716)
Non-profit (5147)
Now hiring (83)
Obesity (882)
Opinion (377)
Ovarian cancer (247)
Pain (288)
Pancreatic cancer (369)
Parkinson's disease (424)
Partnered (41)
Patents (668)
Patient recruitment (791)
Peanut (71)
People (68102)
Pharmaceutical (136)
Pharmacy benefit managers (38)
Phase 1 (24482)
Phase 2 (34421)
Phase 3 (25871)
Pipeline (10041)
Policy (404)
Postmarket research (3560)
Preclinical (10996)
Press Release (72)
Prostate cancer (353)
Psychedelics (73)
Radiopharmaceuticals (376)
Rare diseases (1297)
Real estate (7462)
Recruiting (81)
Regulatory (30527)
Reports (77)
Research institute (2773)
Resumes & cover letters (654)
Rett syndrome (44)
RNA editing (31)
RSV (100)
Schizophrenia (197)
Series A (342)
Series B (250)
Service/supplier (28)
Sickle cell disease (129)
Special edition (32)
Spinal muscular atrophy (191)
Sponsored (55)
Startups (4375)
State (2)
Stomach cancer (21)
Supply chain (149)
Tariffs (104)
The Weekly (146)
Vaccines (1318)
Venture capital (141)
Weight loss (601)
Women's health (146)
Worklife (25)
Date
Today (99)
Last 7 days (490)
Last 30 days (2820)
Last 365 days (33118)
2026 (17199)
2025 (33218)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1297)
Alabama (102)
Alaska (7)
Arizona (409)
Arkansas (16)
Asia (52377)
Australia (9205)
California (14557)
Canada (4065)
China (1616)
Colorado (625)
Connecticut (648)
Delaware (451)
Europe (120763)
Florida (2175)
Georgia (473)
Hawaii (4)
Idaho (70)
Illinois (1271)
India (105)
Indiana (674)
Iowa (26)
Japan (614)
Kansas (144)
Kentucky (57)
Louisiana (64)
Maine (89)
Maryland (1755)
Massachusetts (10666)
Michigan (427)
Minnesota (813)
Mississippi (7)
Missouri (165)
Montana (37)
Nebraska (31)
Nevada (155)
New Hampshire (92)
New Jersey (3860)
New Mexico (35)
New York (3833)
North Carolina (1953)
North Dakota (11)
Northern California (7244)
Ohio (456)
Oklahoma (27)
Oregon (55)
Pennsylvania (2858)
Puerto Rico (33)
Rhode Island (55)
South America (1669)
South Carolina (89)
South Dakota (2)
Southern California (5721)
Tennessee (235)
Texas (2380)
United States (52095)
Utah (434)
Vermont (2)
Virginia (376)
Washington D.C. (89)
Washington State (1192)
West Virginia (4)
Wisconsin (161)
Wyoming (2)
There are 884,836 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Clinilabs Announces New Affiliation With Rutgers University
June 25, 2026
·
3 min read
Press Releases
Racura Oncology Doses First Patient in Phase 1 HARNESS-1 Trial of RC220 in EGFR-Mutant Non-Small Cell Lung Cancer
June 25, 2026
·
6 min read
Press Releases
Gazyva® (obinutuzumab) receives positive reimbursement recommendation from the Institut national d’excellence en santé et en services sociaux (INESSS) for persons with active lupus nephritis
June 25, 2026
·
6 min read
Press Releases
GRAIL Completes $110 Million Equity Financing With Samsung Entities
June 25, 2026
·
9 min read
Press Releases
Former Medtronic CEO Bill Hawkins Joins Ketryx Board to Solve the AI Bottleneck in Life Sciences
June 25, 2026
·
1 min read
Press Releases
Illumisoft Appoints Former White House Chief Healthcare Economist Jonathan Ketcham as Strategic Advisor
Leading health economist joins Illumisoft to support real world adoption of its infection prevention technologies
June 25, 2026
·
6 min read
Press Releases
Envoy Medical Terminates At-the-Market (ATM) Equity Facility
Termination Reflects Company’s Confidence in Current Capital Position
June 25, 2026
·
6 min read
Press Releases
Phio Pharmaceuticals Announces “How siRNA Therapy can Change the Course of Cancer Treatment” in a Fireside Chat with Force Family Office on Monday, June 29, 2026
Live virtual fireside chat - investors, advisors, and life sciences analysts invited to attend
June 25, 2026
·
4 min read
Press Releases
Artificial Intelligence (AI) in Biotechnology Market Size to Exceed USD 31.87 Billion by 2035 Rising Demand for Faster Drug Discovery and Precision Medicine
June 25, 2026
·
1 min read
Mergers & acquisitions
BIO 2026: Forget dual track—biopharma deals are more complex than ever
Dual and even triple or quadruple track processes have come roaring back in 2026 thanks to a glut of M&A that has refilled investors’ wallets. Big Pharma is being put on notice that time is critical if they want to acquire.
June 25, 2026
·
4 min read
·
Annalee Armstrong
1 of 88,484
Next
